AZN - AstraZeneca PLC

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 227.96B
Enterprise Value 253.00B
Trailing P/E 48.86
Forward P/E 19.96
PEG Ratio (5 yr expected) 2.23
Price/Sales (ttm)5.25
Price/Book (mrq)6.39
Enterprise Value/Revenue 5.77
Enterprise Value/EBITDA 22.97

Trading Information

Stock Price History

Beta (5Y Monthly) 0.18
52-Week Change 314.28%
S&P500 52-Week Change 33.90%
52 Week High 376.56
52 Week Low 352.65
50-Day Moving Average 373.04
200-Day Moving Average 366.17

Share Statistics

Avg Vol (3 month) 34.13M
Avg Vol (10 day) 34.46M
Shares Outstanding 53.1B
Implied Shares Outstanding 6N/A
Float 818.59B
% Held by Insiders 10.01%
% Held by Institutions 118.10%
Shares Short (May 14, 2023) 44.67M
Short Ratio (May 14, 2023) 41.24
Short % of Float (May 14, 2023) 4N/A
Short % of Shares Outstanding (May 14, 2023) 40.15%
Shares Short (prior month Apr 13, 2023) 44.02M

Dividends & Splits

Forward Annual Dividend Rate 41.45
Forward Annual Dividend Yield 41.99%
Trailing Annual Dividend Rate 32.90
Trailing Annual Dividend Yield 33.98%
5 Year Average Dividend Yield 42.77
Payout Ratio 496.03%
Dividend Date 3Mar 26, 2023
Ex-Dividend Date 4Feb 22, 2023
Last Split Factor 22:1
Last Split Date 3Jul 26, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 10.73%
Operating Margin (ttm)23.10%

Management Effectiveness

Return on Assets (ttm)6.43%
Return on Equity (ttm)13.05%

Income Statement

Revenue (ttm)43.84B
Revenue Per Share (ttm)2.35
Quarterly Revenue Growth (yoy)-4.50%
Gross Profit (ttm)35.73B
Net Income Avi to Common (ttm)4.7B
Diluted EPS (ttm)1.51
Quarterly Earnings Growth (yoy)367.10%

Balance Sheet

Total Cash (mrq)6.46B
Total Cash Per Share (mrq)0.35
Total Debt (mrq)32.47B
Total Debt/Equity (mrq)90.68
Current Ratio (mrq)0.90
Book Value Per Share (mrq)1.92

Cash Flow Statement

Operating Cash Flow (ttm)9.71B
Levered Free Cash Flow (ttm)9.69B